Connect Sign In
LabMind podcasts
|
July 14, 2021 |
ARUP Laboratories Reduces Turnaround Time on Panel Analysis by 30% with GenomOncology GenomOncology announced that ARUP has chosen to extend its use of the GenomOncology (GO) Precision Oncology API Suite by integrating the GO Clinical Trial and Therapy Matching APIs into its workflows. |
During the pandemic, ARUP hired more people than ever before to fill positions in labs associated with COVID-19 testing. When one of these labs, the Rapid Response Lab, closed, ARUP worked with a hundred employees to help them find other jobs within the company. |
July 8, 2021 | By the time ARUP’s Molecular Genetics COVID-19 Rapid Response Lab closed due to decreased demand, nearly 100 of the 120 employees hired to work in the lab had been placed in new positions at ARUP. |
A donor collection specialist at the ARUP Blood Services Donor Center in Sandy bandages a donor’s arm after she has finished donating blood. ARUP is seeking donations of O-positive and O-negative blood to help address a critical shortage. |
July 6, 2021 | ARUP Blood Services and University of Utah Health join Intermountain Healthcare and the American Red Cross asking Utahns to donate blood. |
President and Chief Medical Officer Tracy George, MD, worked with ARUP’s PharmaDX and Clinical Trials group to create the central pathology review offering used in clinical trials for AYVAKIT. The new precision therapy for advanced systemic mastocytosis recently earned approval from the U.S. Food and Drug Administration. |
July 2, 2021 | The FDA recently approved a new precision therapy developed by Blueprint Medicines for adults with advanced systemic mastocytosis, a rare and potentially fatal hematologic malignancy. |
Adam Barker, PhD, has been named ARUP’s first chief scientific officer. He moves into the role after having spent four years as director of Research and Development. |
July 1, 2021 |
ARUP Appoints Adam Barker, PhD, to Lead Its New Technologies Group Adam Barker, PhD, has been appointed as ARUP’s chief scientific officer, a role in which he will lead the newly formed New Technologies Group. |
A former employee chats with CEO Sherrie L. Perkins, MD, PhD (center), during a reception on June 24, 2021, to celebrate Perkins’ retirement after 31 years at ARUP and the University of Utah. |
June 30, 2021 |
ARUP Welcomes New CEO with Sherrie L. Perkins’ Retirement ARUP Laboratories today bid farewell to CEO Sherrie L. Perkins, MD, PhD, who retired after 31 years with the company and the University of Utah Department of Pathology. Perkins called her retirement “bittersweet” in a companywide message in which she thanked employees. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat